BioSyent (OTCMKTS:BIOYF) Trading Down 0.3% – What’s Next?

BioSyent Inc. (OTCMKTS:BIOYFGet Free Report)’s stock price dropped 0.3% during mid-day trading on Tuesday . The company traded as low as $10.61 and last traded at $10.61. Approximately 652 shares were traded during mid-day trading, a decline of 75% from the average daily volume of 2,596 shares. The stock had previously closed at $10.64.

BioSyent Price Performance

The business has a 50 day moving average price of $10.77 and a 200-day moving average price of $9.32.

About BioSyent

(Get Free Report)

BioSyent Inc is a specialty biopharmaceutical company focused on developing, manufacturing and commercializing pharmaceutical products and medical devices. The company leverages expertise in regulatory affairs, clinical development and manufacturing to deliver a range of branded and generic therapies across multiple therapeutic areas, with particular emphasis on endocrine disorders, supportive care oncology and dermatology.

BioSyent operates a manufacturing facility in Canada that supports both its proprietary portfolio and contract development and manufacturing services (CDMO) for small-molecule products.

Recommended Stories

Receive News & Ratings for BioSyent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSyent and related companies with MarketBeat.com's FREE daily email newsletter.